Clinical Trial Update: Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the optimal dose combination of a calcineurin inhibitor and mycophenolate sodium in kidney transplant recipients has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Calcineurin inhibitor (calcineurin inhibitor)
• Mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Asan Medical Center | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED